4/A: MaxLinear Director Corrects RSU Grant Details

MaxLinear Director Carolyn Beaver filed an amended Form 4 to correct the number of Restricted Stock Units granted on May 20, 2025.

Summary

• Carolyn Beaver, a Director at MaxLinear, Inc. (MXL), filed an amended Form 4 (Form 4/A) on October 10, 2025.
• The purpose of this amendment is to correct the number of Restricted Stock Units (RSUs) previously reported as acquired on May 20, 2025, in the original Form 4 filed on May 22, 2025.
• The corrected number of RSUs acquired by Carolyn Beaver is 15,741.
• Each RSU represents a contingent right to receive one share of MaxLinear, Inc. Common Stock.
• The RSUs will vest 100% on the earlier of May 1, 2026, or the date immediately preceding the next annual meeting of stockholders, contingent on Carolyn Beaver's continued service as a Director.

Sentiment

Score: 6

Explanation: The filing is largely neutral as it's an amendment to correct a previous filing. The underlying event (RSU grant) is a minor positive for director alignment, but the correction itself is neutral to slightly negative due to the initial reporting error.

Positives

• Director Carolyn Beaver's acquisition of 15,741 Restricted Stock Units aligns her interests with shareholders, promoting long-term value creation.

Negatives

• The necessity of filing an amendment indicates an initial reporting error in the previously filed Form 4.

Risks

• The vesting of the 15,741 Restricted Stock Units is contingent upon Carolyn Beaver's continued service as a Director through the specified vesting date.

Future Outlook

The filing details the vesting schedule for the Restricted Stock Units, indicating that 100% of the RSUs will vest on the earlier of May 1, 2026, or the date immediately preceding the next annual meeting of stockholders, subject to continued directorship.

Industry Context

This filing is a routine insider transaction amendment, common for public companies to compensate directors with equity. It does not provide broader industry trends or competitive insights, focusing solely on a specific director's equity compensation correction.

Comparison to Industry Standards

• The grant of Restricted Stock Units to a director as part of an equity incentive plan is a standard practice for public companies, particularly in the technology sector, to align director interests with long-term shareholder value.
• The specified vesting schedule (100% on the earlier of a fixed date or the next annual meeting) is typical for director RSU grants, encouraging retention and long-term commitment.

Corporate Governance

Stakeholder Impact

• Shareholders: The RSU grant to a director fosters alignment of interests between management and shareholders, potentially contributing to long-term value creation.
• Director (Carolyn Beaver): Receives equity compensation, contingent on continued service, which incentivizes long-term commitment to the company.

Next Steps

• Continued service as a Director by Carolyn Beaver to ensure the vesting of the Restricted Stock Units.
• Vesting of 15,741 RSUs on the earlier of May 1, 2026, or the date immediately preceding the next annual meeting of stockholders.

Key Dates

Recommendation

This filing is an amendment to correct a previously reported insider transaction (RSU grant). It does not contain new information regarding the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. The RSU grant itself is a standard form of director compensation, aligning interests, but is not a material event for a 'buy' or 'sell' decision.

Keywords

MaxLinear, MXL, SEC Form 4/A, Restricted Stock Units, RSU, Insider Transaction, Director Compensation, Equity Incentive Plan